Evidence mapPaperPMID 40335709Full record

ArticlePflugers Archiv : European journal of physiology2025

Automated patch-clamp recordings for detecting activators and inhibitors of the epithelial sodium channel (ENaC).

Florian Sure, Markus Rapedius, Alexei Diakov, Marko Bertog, Alison Obergrussberger, Niels Fertig, Christoph Korbmacher, Alexandr V Ilyaskin

Abstract read
In one paragraph

Article in Pflugers Archiv : European journal of physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Florian SureInstitute of Cellular and Molecular Physiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.ORCID 0000-0002-2255-5571
Markus RapediusNanion Technologies GmbH, Munich, Germany.ORCID 0000-0002-9917-9922
Alexei DiakovInstitute of Cellular and Molecular Physiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.ORCID 0009-0005-9926-5707
Marko BertogInstitute of Cellular and Molecular Physiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.ORCID 0000-0002-1504-9582
Alison ObergrussbergerNanion Technologies GmbH, Munich, Germany.ORCID 0000-0002-8748-8947
Niels FertigNanion Technologies GmbH, Munich, Germany.ORCID 0000-0002-9731-2283
Christoph KorbmacherInstitute of Cellular and Molecular Physiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. christoph.korbmacher@fau.de.ORCID 0000-0003-2127-4185
Alexandr V IlyaskinInstitute of Cellular and Molecular Physiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.ORCID 0000-0002-2153-7849

Funding

Deutsche Forschungsgemeinschaft 509149993
6 · The paper itself

Abstract

The epithelial sodium channel (ENaC) is crucial for sodium absorption in several epithelial tissues including lung and kidney. Its involvement in various renal and pulmonary disorders makes ENaC a potential drug target. High-throughput screening using the automated patch-clamp (APC) technique appears to be a promising approach to discover novel ENaC modulators with (patho-)physiological and therapeutic implications. The aim of this methodological study was to establish APC measurements of ENaC-mediated currents. First, we confirmed functional expression of ENaC in a HEK293 cell line stably transfected with human αβγ-ENaC using conventional manual whole-cell patch-clamp recordings. For APC measurements, a standard enzymatic cell-detachment procedure was used to prepare single cell suspensions. This resulted in a high success rate of APC recordings with amiloride inhibitable ENaC currents. Using a γ-inhibitory peptide and the small molecule ENaC activator S3969, we demonstrate that APC recordings could reveal inhibitory as well as stimulatory effects on ENaC. Interestingly, the enzymatic cell-detachment protocol resulted in partial proteolytic ENaC activation. The portion of proteolytically activated channels could be reduced by prolonged incubation of suspended cells in cell culture medium. This recovery protocol enhanced the relative stimulatory effect of chymotrypsin, a prototypical serine protease known to cause proteolytic ENaC activation. Thus, this protocol may be particularly useful for identifying novel ENaC activators mimicking proteolytic channel activation. In conclusion, we have established a high-throughput screening method for the identification of novel ENaC activators and inhibitors using APC.

Indexed as

Epithelial Sodium Channel AgonistsEpithelial Sodium Channel BlockersEpithelial Sodium ChannelsPatch-Clamp TechniquesAmilorideHEK293 CellsHumansAmilorideEpithelial Sodium Channel AgonistsEpithelial Sodium Channel BlockersEpithelial Sodium ChannelsActivatorAutomated patch-clamp (APC)ElectrophysiologyEpithelial sodium channel (ENaC)InhibitorIon channel

Identifiers

PMID40335709
PMCPMC12092551

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.